Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-06

FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental NDA for a generic version of phentermine and topiramate by Prasco Laboratories, authorizing its use for weight management in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phentermine and topiramate (Phentermine and topiramate)

Snippet

SUPPL AP for PHENTERMINE AND TOPIRAMATE (PHENTERMINE AND TOPIRAMATE)